Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: RETRACTED ARTICLE: LncRNA SOX21-AS1 accelerates endometrial carcinoma progression through the miR-7-5p/RAF1 pathway

Fig. 1

SOX21-AS1 expression is increased in EC tissues and cells. A The level of SOX21-AS1 in EC tissues and para-carcinoma tissues assessed by RT-qPCR, n = 30. B The level of MNX1-AS1 in EC cells and ESC. C The ROC curves. D The overall survival rates of EC patients were compared in SOX21-AS1 high-expression and low-expression groups. **P < 0.01,***P < 0.001

Back to article page